24-04-2022, 10:23 PM
https://www.ft.com/content/729f1dc0-32d1...a41f1e8de2
The country is struggling with two problems as it faces its worst Covid-19 surge since the start of the pandemic: the sluggish take-up of booster doses — authorities said this week that only 57 per cent of people over 60 have been fully vaccinated with three jabs — and homegrown vaccines that are much less effective than foreign-produced jabs.
Studies have recommended that China’s Sinovac jab be boosted with a more effective shot, such as one of the mRNA vaccines produced by Germany’s BioNTech and Moderna of the US. With little data on China’s Sinopharm jab, many researchers believe it will also struggle against Omicron.
Eric Topol, director of the Scripps Research Translational Institute, said the data was “limited” but the inactivated vaccines, which are made using a dead part of the virus, were less effective than their rivals and declined further with time.
“The vaccines were at 60 per cent efficacy, it was never rosy, but Omicron really exposed the problem,” he said.
China may have to overcome its reluctance to approve a foreign-made vaccine to tackle the latest outbreak, as well as rapidly rolling out boosters of its domestic shots. Otherwise, it will probably have to impose stricter — and costly — lockdowns to prevent a potentially huge death toll.
Those who kena conned by China Wumao in this forum into taking Sinovac how ? Can still get refund ?
The country is struggling with two problems as it faces its worst Covid-19 surge since the start of the pandemic: the sluggish take-up of booster doses — authorities said this week that only 57 per cent of people over 60 have been fully vaccinated with three jabs — and homegrown vaccines that are much less effective than foreign-produced jabs.
Studies have recommended that China’s Sinovac jab be boosted with a more effective shot, such as one of the mRNA vaccines produced by Germany’s BioNTech and Moderna of the US. With little data on China’s Sinopharm jab, many researchers believe it will also struggle against Omicron.
Eric Topol, director of the Scripps Research Translational Institute, said the data was “limited” but the inactivated vaccines, which are made using a dead part of the virus, were less effective than their rivals and declined further with time.
“The vaccines were at 60 per cent efficacy, it was never rosy, but Omicron really exposed the problem,” he said.
China may have to overcome its reluctance to approve a foreign-made vaccine to tackle the latest outbreak, as well as rapidly rolling out boosters of its domestic shots. Otherwise, it will probably have to impose stricter — and costly — lockdowns to prevent a potentially huge death toll.
Those who kena conned by China Wumao in this forum into taking Sinovac how ? Can still get refund ?
